Molecular Magnetic Resonance Imaging of Coronary Thrombosis and Pulmonary Emboli With a Novel Fibrin-Targeted Contrast Agent

Background—The differential diagnosis of acute chest pain is challenging, especially in patients with normal ECG findings, and may include coronary thrombosis or pulmonary emboli. The aim of this study was to investigate the novel fibrin-specific contrast agent EP-2104R for molecular targeted MR imaging of coronary thrombosis and pulmonary emboli. Methods and Results—Fresh clots were engineered ex vivo from human blood and delivered in the lungs and coronary arteries of 7 swine. Subsequent molecular MR imaging was performed with a navigator-gated free-breathing and cardiac-triggered 3D inversion-recovery black-blood gradient-echo sequence before and after systemic administration of 7.5 &mgr;mol/kg EP-2104R. Two swine served as the control group. MR images were analyzed by 2 investigators, and contrast-to-noise ratio and gadolinium concentration in the clots were assessed. Before contrast media application, no thrombi were visible. After contrast administration, all 32 pulmonary emboli, 3 emboli in the right heart, and 5 coronary thrombi were selectively visualized as white spots with a mean contrast-to-noise ratio of 32±19. The average gadolinium concentration from all 3 types of thrombi was 144±79 &mgr;mol/L. Conclusions—Molecular MR imaging with the fibrin-targeted contrast-agent EP-2104R allows selective visualization of acute coronary, cardiac, and pulmonary thrombi.

[1]  R W Parkey,et al.  Fast short-tau inversion-recovery MR imaging. , 1991, Radiology.

[2]  G G King,et al.  Spiral computed tomography is comparable to angiography for the diagnosis of pulmonary embolism. , 2000, American journal of respiratory and critical care medicine.

[3]  V. Tapson,et al.  Clinical practice. The evaluation of suspected pulmonary embolism. , 2003, The New England journal of medicine.

[4]  René M. Botnar,et al.  In Vivo Molecular Imaging of Acute and Subacute Thrombosis Using a Fibrin-Binding Magnetic Resonance Imaging Contrast Agent , 2004, Circulation.

[5]  René M. Botnar,et al.  Navigator-Gated Coronary Magnetic Resonance Angiography Using Steady-State-Free-Precession: Comparison to Standard T2-Prepared Gradient-Echo and Spiral Imaging , 2003, Investigative radiology.

[6]  B. Gersh,et al.  Current management of non-ST-segment-elevation acute coronary syndrome: reconciling the results of randomized controlled trials. , 2003, European heart journal.

[7]  V. Tapson,et al.  The Evaluation of Suspected Pulmonary Embolism , 2003 .

[8]  C. Kramer.  Magnetic resonance imaging to identify the high-risk plaque. , 2002, The American journal of cardiology.

[9]  Sheng-Kwei Song,et al.  High‐resolution MRI characterization of human thrombus using a novel fibrin‐targeted paramagnetic nanoparticle contrast agent , 2000, Magnetic resonance in medicine.

[10]  C A Beam,et al.  1992 ARRS Executive Council Award. Detection of deep venous thrombosis: prospective comparison of MR imaging with contrast venography. , 1993, AJR. American journal of roentgenology.

[11]  René M. Botnar,et al.  Three‐dimensional high‐resolution fast spin‐echo coronary magnetic resonance angiography , 2001, Magnetic resonance in medicine.

[12]  M. Kontos.  Evaluation of the Emergency Eepartment Chest Pain Patient , 2001, Cardiology in review.

[13]  H. Katus,et al.  Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. , 2000, Circulation.

[14]  Rentrop Kp.  Thrombi in Acute Coronary Syndromes Revisited and Revised , 2000 .

[15]  V. Fuster,et al.  In vivo noninvasive detection and age definition of arterial thrombus by MRI. , 2002, Journal of the American College of Cardiology.

[16]  S A Wickline,et al.  Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.

[17]  V. Tapson.  Pulmonary embolism--new diagnostic approaches. , 1997, The New England journal of medicine.

[18]  M. Pistolesi,et al.  Accuracy of clinical assessment in the diagnosis of pulmonary embolism. , 1999, American journal of respiratory and critical care medicine.

[19]  J. Remy,et al.  Non-traumatic thoracic emergencies: CT diagnosis of acute pulmonary embolism: the first 10 years , 2002, European Radiology.

[20]  T Suzuki,et al.  Considerable Time From the Onset of Plaque Rupture and/or Thrombi Until the Onset of Acute Myocardial Infarction in Humans: Coronary Angiographic Findings Within 1 Week Before the Onset of Infarction , 2000, Circulation.

[21]  V. Fuster,et al.  Pathogenetic concepts of acute coronary syndromes. , 2003, Journal of the American College of Cardiology.

[22]  V. Fuster,et al.  Coronary plaque disruption. , 1995, Circulation.

[23]  P. J. Drury,et al.  Acute pulmonary embolism: diagnosis with MR angiography. , 1999, Radiology.

[24]  Martine Remy-Jardin,et al.  Pulmonary embolus imaging with multislice CT. , 2003, Radiologic clinics of North America.

[25]  T L Chenevert,et al.  Diagnosis of pulmonary embolism with magnetic resonance angiography. , 1997, The New England journal of medicine.

[26]  René M. Botnar,et al.  In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent , 2004, Circulation.

[27]  V. Fuster,et al.  Is There a Vulnerable Plaque? , 2003, Circulation.

[28]  Anne L. Martel,et al.  Characterization of Complicated Carotid Plaque With Magnetic Resonance Direct Thrombus Imaging in Patients With Cerebral Ischemia , 2003, Circulation.

[29]  K. Rentrop.  Thrombi in acute coronary syndromes : revisited and revised. , 2000, Circulation.

[30]  S. Daeschner.  Pulmonary embolism. , 1988, Nursing.

[31]  B Ghaye,et al.  Peripheral pulmonary arteries: how far in the lung does multi-detector row spiral CT allow analysis? , 2001, Radiology.

[32]  René M. Botnar,et al.  Coronary magnetic resonance angiography for the detection of coronary stenoses. , 2001, The New England journal of medicine.